Clinical Trial Update: Abraxane Therapy in Patients With Pancreatic Cancer Who Failed First-Line Gemcitabine Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial of Abraxane (paclitaxel protein-bound) in patients with pancreatic cancer after failure of first-line gemcitabine; the study completed with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)

Snippet

Sponsor: University of Miami | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED | Results posted: 2013-11-15